Technological Advances Shaping the Future of Medical Aesthetics Market
https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html
The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. The rising prevalence of targeted diseases and increasing technological advancements fuel the market growth.
The medical aesthetics market is moderately competitive, with established companies and upcoming competitors for the same market share. As of 2022, the key players operating in the global medical aesthetics market are Abbvie Inc (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), and Cutera. (US) among others.
https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html
The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. The rising prevalence of targeted diseases and increasing technological advancements fuel the market growth.
The medical aesthetics market is moderately competitive, with established companies and upcoming competitors for the same market share. As of 2022, the key players operating in the global medical aesthetics market are Abbvie Inc (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), and Cutera. (US) among others.
Technological Advances Shaping the Future of Medical Aesthetics Market
https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html
The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. The rising prevalence of targeted diseases and increasing technological advancements fuel the market growth.
The medical aesthetics market is moderately competitive, with established companies and upcoming competitors for the same market share. As of 2022, the key players operating in the global medical aesthetics market are Abbvie Inc (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), and Cutera. (US) among others.
0 Commenti
0 condivisioni
0 Anteprima